A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy.
Vasily GiannakeasSteven A NarodPublished in: Breast cancer research and treatment (2019)
The clinical course of women with low-risk ER-positive breast cancer is inherently unpredictable and consequently death is equally as likely to occur at year 3 than at year 20.